tanshinone has been researched along with Cardiomegaly in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 5 (55.56) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Chen, H; Chen, Y; Pang, L; Shen, Y; Wu, W; Yu, Z; Zhang, M | 1 |
Chen, RJ; Chen, YF; Chung, LC; Huang, CY; Kuo, WW; Lee, NH; Padma Viswanadha, V; Pai, PY; Rajendran, P; Shen, CY | 1 |
Chen, HW; Feng, J; Pi, LJ; Wang, J; Zhan, DQ | 1 |
He, XX; Liang, QS; Zhan, CY; Zhou, DX | 1 |
Li, Y; Liang, Q; Yang, Y; Yu, D | 1 |
Liang, QS; Tu, EY; Wang, ZH; Yang, GT; Zhou, YG | 1 |
Li, YS; Yan, L; Yong, YQ | 1 |
Cai, B; Chen, N; Dong, D; Li, J; Li, X; Liu, Y; Lu, Y; Shan, H; Tan, X; Wang, G; Wang, X; Yang, B; Yang, F; Zhang, P | 1 |
Bao, Y; Fang, J; Gao, J; Liu, P; Mou, YG; Pi, R; Wang, P; Wu, X; Zhou, S | 1 |
9 other study(ies) available for tanshinone and Cardiomegaly
Article | Year |
---|---|
Tanshinone IIA alleviates cardiac hypertrophy through m6A modification of galectin-3.
Topics: Abietanes; Animals; Cardiomegaly; Drugs, Chinese Herbal; Galectin 3; Humans; Male; Methylation; Mice; Mice, Inbred C57BL; Salvia miltiorrhiza; Signal Transduction | 2022 |
Tanshinone-induced ERs suppresses IGFII activation to alleviate Ang II-mediated cardiac hypertrophy.
Topics: Abietanes; Angiotensin II; Animals; Cardiomegaly; Cell Line; Drugs, Chinese Herbal; Gene Expression; Heat Shock Transcription Factors; Humans; Insulin-Like Growth Factor II; Mitogen-Activated Protein Kinase Kinases; Myocytes, Cardiac; Rats; Receptor, IGF Type 2; Receptors, Estrogen; Signal Transduction; Sirtuin 1 | 2017 |
Protective effect of tanshinone IIA against cardiac hypertrophy in spontaneously hypertensive rats through inhibiting the Cys-C/Wnt signaling pathway.
Topics: Abietanes; Animals; Arginine; Cardiomegaly; Cardiovascular Agents; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type III; Cystatin C; Disease Models, Animal; Hypertension; Male; Myocardium; NADPH Oxidase 4; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphorylation; Rats, Inbred SHR; Rats, Inbred WKY; Time Factors; Troponin I; Wnt Signaling Pathway | 2017 |
[Changes of c-fos, c-jun mRNA expressions in cardiomyocyte hypertrophy induced by angiotensin II and effects of tanshinone II A].
Topics: Abietanes; Angiotensin II; Animals; Cardiomegaly; Gene Expression Regulation; Genes, fos; Genes, jun; Myocytes, Cardiac; Phenanthrenes; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Rats; Rats, Wistar; RNA, Messenger; Tetrazoles; Valine; Valsartan | 2008 |
The effect of tanshinone IIA upon the TGF-beta1/Smads signaling pathway in hypertrophic myocardium of hypertensive rats.
Topics: Abietanes; Animals; Cardiomegaly; Drugs, Chinese Herbal; Female; Hypertension; Male; Protective Agents; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Signal Transduction; Smad Proteins; Transforming Growth Factor beta1 | 2009 |
Effects of tanshinone II A on the myocardial hypertrophy signal transduction system protein kinase B in rats.
Topics: Abietanes; Animals; Cardiomegaly; Drugs, Chinese Herbal; Phenanthrenes; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction | 2009 |
[Effect of tanshinone II A on the transforming growth factor beta1/Smads signal pathway in rats with hypertensive myocardial hypertrophy].
Topics: Abietanes; Animals; Cardiomegaly; Drugs, Chinese Herbal; Hypertension; Myocardium; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Signal Transduction; Smad Proteins; Transforming Growth Factor beta1 | 2010 |
Tanshinone IIA protects against cardiac hypertrophy via inhibiting calcineurin/NFATc3 pathway.
Topics: Abietanes; Animals; Atrial Natriuretic Factor; Calcineurin; Calcium Signaling; Cardiomegaly; Drugs, Chinese Herbal; Isoproterenol; Medicine, Chinese Traditional; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptide, Brain; NFATC Transcription Factors; Rats; RNA, Messenger; Up-Regulation | 2011 |
Tanshinone IIA prevents cardiac remodeling through attenuating NAD (P)H oxidase-derived reactive oxygen species production in hypertensive rats.
Topics: Abietanes; Animals; Blotting, Western; Cardiomegaly; Cardiotonic Agents; Coronary Circulation; Enzyme Inhibitors; Fibrosis; Heart Diseases; Hemodynamics; Hypertension, Renovascular; Male; Myocardium; NADPH Oxidases; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; Stroke Volume; Ultrasonography; Ventricular Dysfunction, Left | 2011 |